Skip to main content

Table 1 Tumor incidence of SP cells and non-SP cells in vivo

From: Differentiation therapy: sesamin as an effective agent in targeting cancer stem-like side population cells of human gallbladder carcinoma

Cell population 106 105 104 103 102
Tumors Tumors Tumors Tumors Tumors
SP(SGC-996) 4/4 4/4 3/4 2/4 2/4
Non-SP(SGC-996) 4/4 2/4 1/4 0/4 0/4
SP(GBC-SD) 4/4 4/4 4/4 2/4 2/4
Non-SP(GBC-SD) 4/4 3/4 2/4 0/4 0/4
  1. Increased tumorigenicity of SP cells when injected subcutaneously into nude mice (n = 4 per group). The observational period lasted for six weeks.